ACBD5 and X-linked adrenoleukodystrophy: ACBD5-deficient patients typically exhibit a 1.2-fold elevation of VLCFA over healthy individuals, while X-ALD patients exhibit an average of 4.5-fold elevation (Moser et al., 1999).